ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: Which patients benefit, which patients don't?

Digestive Diseases and Sciences

Volumn 44, Issue 7, 1999, Pages 1298-1302

  Martin, John A ^a   Slivka, Adam ^a   Rabinovitz, Mordechai ^a   Carr, Brian I ^a   Wilson, John ^a   Silverman, William B ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Biliary stricture; Endoscopic retrograde cholangiopancreatography; Hepatocellular carcinoma; Stent

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT DILATATION; BILE DUCT OBSTRUCTION; CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; JAUNDICE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; STENT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLESTASIS; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PATIENT SELECTION; STENTS; TREATMENT OUTCOME;

EID: 0032783529     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026618927885     Document Type: Article

References (24)

1. 1. Colleoni M, Gaion F, Liessi G, Mastropasqua G, Nelli P, Manente P: Medical treatment of hepatocellular carcinoma: Any progress? Tumori 80:315-326, 1994
2. 2. Ramsey WH, Wu GY: Hepatocellular carcinoma: Update on diagnosis and treatment. Dig Dis Sci 13:81-91, 1995
3. 3. Kirk JME, Skipper D, Joseph AEA, Knee G, Grundy A: Intraluminal bile duct hepatocellular carcinoma. Clin Radiol 49:886-888, 1994
4. 4. Lau W-Y, Leung WC, Li AKC: Management of hepatocellular carcinoma presenting as obstructive jaundice. Am J Surg 160:280-282, 1990
5. 5. Lai ST, Lab KT, Lee KC: Biliary tract invasion and obstruction by hepatocellular carcinoma: Report of five cases. Postgrad Med J 68:961-963, 1992
6. 6. Kubota Y, Seki T, Kunieda K, Nakahashi Y, Tani K, Nakatani S, Yamaguchi T, Mizuno T, Inoue K: Biliary endoprosthesis in bile duet obstruction secondary to hepatocellular carcinoma. Abdom Imaging 18:70-75, 1993
7. 7. Kozarek RA: Endoscopy in the management of malignant obstructive jaundice. Gastrointest Endosc Clin North Am 6:153-176, 1996
8. 8. Silverman WB, Grieser EW: Revised concept of an ERCP database as a research tool: Simple is better. Gastrointest Endosc 39(2):A257, 1996 (abstract)
9. 9. Cotton PB: Endoscopic methods for relief of malignant obstructive jaundice. World J Surg 8:854-861, 1984
10. 10. Ueno Y, Larusso NF: Primary sclerosing cholangitis. J Gastroenterol 29:531-543, 1994
11. 11. Knyrim K, Wagner HJ, Pausch J, Vakil N: A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 25:207-212, 1993
12. 12. Vij JC, Govil A, Chaudhary MS, Gulati R, Mehta S, Ganguli S: Endoscopic biliary endoprosthesis for palliation of gallbladder carcinoma. Gastrointest Endosc 43:121-123, 1996
13. 13. Moore D, Jr., Pazdur R: Systemic therapies for unresectable primary hepatic tumors. J Surg Oncol Suppl 3:112-114, 1993
14. 14. Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML: Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 35:467-470, 1994
15. 15. Polydorou AA, Cairns SR, Dowsett JF, Hatfield ARW, Salmon PR, Cotton PB, Russel RCG: Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 32:685-689, 1991
16. 16. Huddart RA, Hubbard CS ff, Dickinson RJ: Biliary stenting for malignant jaundice: A district hospital experience. Clin Radiol 43:103-106, 1991
17. 17. Shepherd HA, Royle G, Ross APR, Diba A, Arthur M, Colin-Jones D: Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: A randomized trial. Br J Surg 75:1166-1168, 1988
18. 18. Huibregtse K, Tytgat GN: Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis: Experience in 45 patients. Gut 23:371-375, 1982
19. 19. Carr BI, Iwatsuki S, Starzl TE, Selby R, Madariaga J: Regional cancer chemotherapy for advanced stage hepatocellular carcinoma. J Surg Oncol Suppl 3:100-103, 1993
20. 20. Ravoet C, Bleiberg H, Gerard B: Non-surgical treatment of hepatocellular carcinoma. J Surg Oncol Suppl 3:104-111, 1993
21. 21. Rougier P, Roche A, Pelletier G, Ducreux M, Pignon JP, Etienne JP: Efficacy of chemoembolization for hepatocellular carcinomas: Experience from the guslave roussy institute and the Bicêtre Hospital. J Surg Oncol Suppl 3:94-96, 1993
22. 22. Baillie J: Complications of Endoscopy. Endoscopy 26:185-203, 1994
23. 23. Cotton PB, Lehman G, Vennes J, Geenen JE, Russel RCG, Meyers WC, Liguory C, Nicki N: Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 37:383-393, 1991
24. 24. Leese T, Neoptolemos JP, Carr-Locke DL: Successes, failures, early complications and their management following endoscopic sphincterotomy: Results in 394 consecutive patients from a single centre. Br J Surg 72:215-219, 1985